Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Araz, E. Yilmazel Ucar, Y. Aydin, M. Meral, Y. Bilen, F. Alper, A. M. Görgüner, M. Akgun (Erzurum, Turkey). Effects of lymphadenopathy on pulmonary function tests in sarcoidosis. Eur Respir J 2012; 40: Suppl. 56, 3625

Member's Comments

No comment yet.

Related content which might interest you: Correlation among pulmonary function tests and radiologic involvement in the monitoring of sarcoidosis Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020 Pulmonary function impairment in newly diagnosed pulmonary sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 135s Year: 2001 Temporal changes in mediastinal lymphadenopathy in patients with idiopathic pulmonary fibrosis Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Pulmonary function tests in childhood scleroderma Source: Eur Respir J 2006; 28: Suppl. 50, 307s Year: 2006 Comprehensive evaluation of airway involvement in pulmonary sarcoidosis Source: ERJ Open Res, 3 (1) 00105-2016; 10.1183/23120541.00105-2016 Year: 2017 Renal involvement in chronic pulmonary sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 550s Year: 2005 Pulmonary disease in primary Sjögren´s syndrome: symptoms, pulmonary function tests and HRCT Source: Eur Respir J 2004; 24: Suppl. 48, 487s Year: 2004 Correlation of erithema nodosum with active pulmonary sarcoidosis based on bronchial biopsy data Source: Eur Respir J 2003; 22: Suppl. 45, 265s Year: 2003 Does concomitant extrapulmonary involvement changes characteristic features of pulmonary sarcoidosis? Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Pulmonary symptoms and pulmonary function tests of the welders Source: Annual Congress 2009 - Air pollution and other exposures Year: 2009 Effects of oral dual ERA therapy on pulmonary function testing and 6MWT in patients with idiopathic pulmonary fibrosis and pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH Year: 2012 Pathogenesis of pulmonary fibrosis in sarcoidosis Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ? Year: 2020 Evaluation of the functional parameters in scleroderma cases with pulmonary involvement Source: Annual Congress 2009 - Respiratory physiology Year: 2009 Pulmonary function tests as predictors of mortality in patients with sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Gender differences in serial pulmonary function testing in idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 579s Year: 2007 Changes in pulmonary function tests following antibiotics in infants with pulmonary exacerbation of cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment Year: 2013 Assessing of the liver function tests in patients with acute pulmonary embolism Source: Eur Respir J 2005; 26: Suppl. 49, 522s Year: 2005 Differential diagnosis of pulmonary eosinophilia Source: Eur Respir Monogr 2022; 95: 19-36 Year: 2022 Change in pulmonary function among patients with bronchiectasis with or without non-tuberculous mycobacterial pulmonary disease Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019